These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14388598)

  • 1. Serum antiplasmin and plasmin in rheumatoid arthritis.
    THOMAS DP; DINGLE JT
    Ann Rheum Dis; 1955 Jun; 14(2):195-7. PubMed ID: 14388598
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the enzymatic activity in rheumatoid arthritis. II. The antiplasmin action of serum in patients with rheumatoid arthritis.
    HAMMARSTEN G; JONSSON E
    Acta Med Scand; 1954; 147(5-6):363-6. PubMed ID: 13157912
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.
    NORMAN PS; HILL BM
    J Exp Med; 1958 Nov; 108(5):639-49. PubMed ID: 13587848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD; Harpel PC
    J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification of bovine antiplasmin (antifibrinolysin).
    COLE ER; DALBY A; MERTZ ET
    Can J Biochem Physiol; 1960 Sep; 38():1021-7. PubMed ID: 13811110
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 8. The antiplasmin effect of plasma fractions.
    RYBAK M; REJNEK J
    Clin Chim Acta; 1959 May; 4(3):364-8. PubMed ID: 13663237
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
    Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
    Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268
    [No Abstract]   [Full Text] [Related]  

  • 11. [On plasmin and antiplasmin titration].
    KOTSCHY M
    Postepy Hig Med Dosw; 1961; 15():607-15. PubMed ID: 14458817
    [No Abstract]   [Full Text] [Related]  

  • 12. Relative antiplasmin (antifibrinolysin) activity of omega-aminocarboxylic acids.
    MIYAMOTO M; LEE KH
    J Pharm Sci; 1962 Sep; 51():912-3. PubMed ID: 14474810
    [No Abstract]   [Full Text] [Related]  

  • 13. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of antiplasmin activity of urine].
    Obodchuk GS; Byshevskiĭ ASh
    Lab Delo; 1976; (1):50-1. PubMed ID: 56493
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 cases of acute fibrinolysis treated with success by plasmin inhibitor. Survival. Secondary death].
    MATHEY J; CORMIER JM; AIGUEPERSE J; LALARDRIE JP; HAEGEL A
    Mem Acad Chir (Paris); 1961 Feb 1-8; 87():155-61. PubMed ID: 13768100
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the enzymatic activity in rheumatoid arthritis. I. The activity of plasmin in plasma from patients with rheumatoid arthritis.
    HAMMARSTEN G; JONSSON E; HANSEN J
    Acta Med Scand; 1954; 147(5-6):359-62. PubMed ID: 13157911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alpha 2-plasmin inhibitor-plasmin complex].
    Yoshikawa Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():685-7. PubMed ID: 10543213
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (Ipsilon) administration].
    YAMASHITA H; IGARI S; TANAKA T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1961 Sep; 21():646-55. PubMed ID: 14008906
    [No Abstract]   [Full Text] [Related]  

  • 20. On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (ipsilon) administration.
    YAMASHITA H; IGARI S; TANAKA T
    Keio J Med; 1961 Dec; 10():195-207. PubMed ID: 14008905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.